Joint Multidisciplinary Team Begins Intensive Investigation in Gujarat and Rajasthan
A joint team comprising specialists from the National Centre for Disease Control, Indian Council of Medical Research and the Department of Animal Husbandry and Dairying has been mobilised to the hotspots of Chandipura virus in Gujarat and Rajasthan. The team’s work is synchronised with state surveillance units under the Integrated Disease Surveillance Programme (IDSP).
Their mandate includes detailed field investigation, epidemiological mapping, clinical case management, laboratory coordination and vector monitoring. By collaborating with state health departments, the team will assess on‑ground responses, identify gaps, and submit actionable recommendations to the Union Ministry.
The response team draws expertise from several ICMR institutes: the National Institute of Epidemiology (NIE) in Chennai, the National Institute of Vector‑ borne Disease Research (NIVDR) in Puducherry, the National Institute of Virology (NIV) in Pune, and the National Institute for Pre‑clinical Research (NIPCR) in Hyderabad, as well as the Indian Council of Agricultural Research’s Animal Epidemiology institute in Bengaluru. Together, they are examining the full clinical spectrum of CHPV infection, from mild fever to severe acute encephalitis syndrome (AES).
Intensive active surveillance for acute febrile illness (AFI) and AES has been launched across affected districts. Community‑level serosurveys are being conducted to capture silent infections and to gauge the true extent of viral spread. Laboratory teams are upgrading diagnostic platforms and developing robust animal models to study disease mechanisms.
Vector studies are a cornerstone of the investigation. While sand‑flies remain the primary suspect, researchers are systematically testing mosquitoes, culicine flies and smaller arthropods for potential involvement. Thousands of specimens collected from the field are now undergoing molecular analysis in high‑security laboratories.
Parallel animal surveillance activities target domestic livestock that could act as reservoirs. Blood and milk samples from cattle, buffaloes and goats—approximately 70 specimens to date—are being screened for Chandipura virus and related pathogens. No definitive findings have been released pending laboratory confirmation.
The team is also re‑examining the 2024 Gujarat outbreak, where extensive vector sampling did not yield a single conclusive carrier, underscoring the complexity of CHPV transmission dynamics.
Genomic sequencing of current virus isolates is in progress at the Gujarat Biotechnology Research Centre (GBRC). Initial data reveal subtle genetic differences; however, comprehensive comparative genomics will be required to ascertain whether the present strain represents an evolved lineage.
Support comes from India’s hospital‑based Acute Encephalitis Syndrome (AES) surveillance network, which operates across 15 tertiary care hospitals. Using uniform clinical protocols, serological and molecular diagnostics, and next‑generation sequencing, the network enhances early detection, clarifies AES aetiology and informs rapid public health interventions.
By integrating human health, animal health and vector surveillance, the joint multidisciplinary team embodies a One Health strategy aimed at curbing the Chandipura virus outbreak.